
CryoEM Current Practices Webinar: Strategies and Highlights from the National CryoEM Centers
- When
- Length
- 1 hr
- Platform
- Zoom
- Topic
- Medical & Clinical
- Price
- Free
About this webinar
Wei-Jen Tang, University of Chicago & Venkata Dandey, University of Connecticut Health Science: Advancing cryoEM studies of amyloid-peptide degrading proteases through national facility collaboration.
Abstract
Aggregates of amyloidogenic peptides are highly cytotoxic, as exemplified by the role of amyloid-β (Aβ) in Alzheimer’s disease. Several metalloproteases, including the M16-family insulin-degrading enzyme (IDE) and presequence peptidase (PreP), as well as the M2-family angiotensin-converting enzyme (ACE), share the ability to degrade amyloid peptides in addition to their distinct physiological peptide substrates. These enzymes undergo large open-to-closed conformational transitions that enable selective substrate capture, reorientation or partial unfolding, and proteolysis. Although closed-state structures were established earlier by crystallography, open-state and/or full-length structures have only recently become accessible through cryo-EM. In this presentation, we will describe our efforts to overcome key grid-preparation challenges in solving cryo-EM structures of IDE, PreP, and ACE, both alone and in complexes with functionally relevant substrates and inhibitors. Using access through general user programs (GUPs 1–3), we evaluated multiple vitrification strategies, including Spotiton/Chameleon-based sample deposition and detergent screening workflows, to improve particle behavior and data quality. We will also discuss the NIEHS-led development of VitriFlex, an open-source, modular, and customizable robotic platform for cryo-EM grid preparation, and compare its performance with Chameleon for structure determination of ACE bound to FDA-approved inhibitors.
Hosted jointly by NCCAT, PNCC, & S2C2

